Systems biology is emerging as a comprehensive science to accomplish more accurate modelling of complex diseases as a result of recent developments in high-throughput technologies. Many believe that personalised medicine will become more prevalent soon. Nonetheless, two-tiered personalised medicine is replacing two-tiered health systems. Omics facilities are only found in wealthy areas, and personalised medicine will probably make the already widening divide between high- and low-income countries' health systems even wider. An increasing lag between our capacity to produce and evaluate large amounts of data reflects this. The move from conventional to personalised medicine is slowed down by a number of bottlenecks, including the production of high-throughput data at a reasonable cost, on a personal and global scale. This paper offers a current overview of significant advancements in big data analysis as well as future directions for quickening the global shift to personalised medicine. Genetic illness affects almost all medical fields.
9 February 2026 in International Journal of Image and Graphics